Anhui Wellman Pharmaceutical

Anhui Wellman Pharmaceutical Co., Ltd., established in 1992, is a pharmaceutical company based in Hefei, China, and a key subsidiary of the Welman Group (Xiangbei Welman Pharmaceutical). The company specializes in the research, development, and large-scale manufacturing of active pharmaceutical ingredients (APIs) and finished dosage forms, with a strong focus on antibiotic combination products and respiratory medications. It operates nine GMP-compliant production lines covering various formulations such as powder for injection, soft capsules, and aerosols. Anhui Wellman is recognized for its expertise in beta-lactamase inhibitors and has a diverse portfolio including piperacillin/tazobactam, ciclesonide, and various cephalosporin-based antibiotics. The company serves both domestic and international markets, leveraging its advanced manufacturing capabilities to provide high-quality generic and innovative pharmaceutical products.